ALZA

pharmaceutical products, namely, those in specialized dosage forms, namely, transdermal plasters and transdermal patches used in pain relief, treatment of hypogonadism, and smoking cessation; iontophoretic patches for use in pain relief; controlled drug-releasing polymer matrices, for use in treatment of conditions of the oral cavity; and pharmaceutical products in conventional dosage forms, namely, fungicides, for treating oral fungal infections, alkalinizing agents for maintaining alkaline urine, alkalinizing agents for treating acidosis, alkalinizing agents for neutralizing gastric acid, bladder control drugs, anti-cancer drugs, drugs for relieving bladder pain, drugs for treating interstitial cystitis, drugs for reducing toxicity associated with chemotherapy, drugs for treating oral candidiasis, dietary and nutritional supplements, and drugs for use in the field of urology and oncology; and osmotic pumps for use in delivering cough/cold medications and for use in the field of urology and oncology

implantable drug delivery devices for use in experimental animals and for administering leuprolide in the treatment of prostate cancer